🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Material Elimination

According to TikTok, the platform has removed problematic content and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or administering at residence.

Within moments of joining one group, a vendor posted contact information, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts show dark colored packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by personal administration from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to potentially significant medical dangers”.